Abstract 20500: Mammalian Target of Rapamycin (mTOR) Suppresses Intrinsic Death Pathway Activation via NF-κB linked-IKKβ Dependent Pathway in Ventricular Myocytes
The signaling networks that coordinate cell survival and cell death are poorly defined in the heart. The mammalian target of rapamycin (mTOR) is a highly conserved serine threonine kinase centrally involved in vital processes including growth, proliferation, and gene transcription. However, mTOR's role in regulating cell survival under normal or disease conditions has not been undetermined. Previously, we established a cytoprotective role for the cellular factor NF-κB in ventricular myocytes. Notably, we demonstrated that NF-κB activation was necessary and sufficient for basal cell survival and suppressing mitochondrial perturbations during hypoxic injury. Herein, we provide new compelling evidence that activation of IKK-NF-κB signaling pathway down-stream of mTOR suppresses mitochondrial perturbations and cell death during metabolic stress imposed by nutrient deprivation or hypoxia. In contrast to wild type cells, constitutive activation of mTOR in tuber sclerosis complex knockout cells (TSC1/TSC2−/−) displayed marked increase in mTOR targets p-P70S6, p-4EBP-1 and S6 protein. Interestingly, a significant increase in nuclear NF-κB activity and NF-κB gene transcription was also observed in TSC1/TSC2−/− cells. However, basal NF-κB activity and cell viability were significantly reduced upon mTOR inactivation following metabolic stress or hypoxia. Moreover, basal Bnip3 gene transcription and cell death were significantly increased in cells defective for mTOR activity. IKKβ-mediated activation of NF-κB restored mTOR activity and suppressed cell death induced by Bnip3. To our knowledge, our data provide the first direct evidence that operationally links mTOR and cell survival via IKKβ-NF-κB mediated repression of Bnip3.
- © 2010 by American Heart Association, Inc.